Page 5 - Immunic Inc Nasdaq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic inc nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Nasdaq Today - Breaking & Trending Today

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […] ....

Jpmorgan Chase Co , Metlife Investment Management , Vontobel Holding Ltd , Marshall Wace , Immunic Inc , Free Report , Get Free Report , Life Investment Management , Immunic Daily , Nasdaq Imux , Reiterated Rating ,

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for. ....

Paula Schwartz , Edna Kaplan , Jessica Breu , Exchange Commission , Prnewswire Immunic Inc , Immunic Inc , Rx Communications Group , Private Securities Litigation Reform Act , Annual Report , Investor Relations ,

With 50% stake, Immunic, Inc. (NASDAQ:IMUX) seems to have captured institutional investors' interest

Key Insights Institutions' substantial holdings in Immunic implies that they have significant influence over the. ....

Daniel Vitt , Immunic Inc , Ndividual Investors , Nsider Ownership , Shares Outstanding ,

Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 6.9% in June

Immunic, Inc. (NASDAQ:IMUX – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 2,170,000 shares, a growth of 6.9% from the June 15th total of 2,030,000 shares. Based on an average daily volume of 1,040,000 shares, the […] ....

Immunic Inc , Immunic Company Profile , Schonfeld Strategic Advisors , Geode Capital Management , Get Free Report , Street Corp , Capital Management , Strategic Advisors , Global Management , Two Sigma Investments , Sigma Investments , Immunic Daily , Nasdaq Imux ,

Immunic to Participate in Scientific and Investor Conferences in July

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for. ....

United States , New York , Beth Israel Medical Center , Adams Center , Josepha Murray , Jessica Breu , Friedrich Hahn , Paula Schwartz , J Thomas Lamont , Edna Kaplan , Martina Wirth , Beth Israel Deaconess Medical Center , Institute For Clinical , Celiac Disease Research , Adams Center Ancillary Gyms , Division Of Gastroenterology , Department Of Internal Medicine , Shirley Berry Professor Of Gastrointestinal Sciences , Celiac Center , Selective Small Molecules Directed To Nuclear Receptor , Securities Therapeutics Forum Daniel Vitt , International Herpesvirus Workshop , Rx Communications Group , Harvard Medical School , Immunic Inc , Exchange Commission ,